A study was conducted to determine whether treatment with deslorelin, a gonadotropin-releasing hormone (GnRH) analog, produced anestrus in gilts and to test the ability of exogenous gonadotropin treatment with a combination of 400 IU equine chorionic gonadotropin and 200 IU human chorionic gonadotropin to induce estrus in GnRH analog-treated gilts. Twelve days after the third estrus, 11 gilts e...

Intraperitoneal injection of human chorionic gonadotropin in the rat induces a dose-dependent frequency of ovarian hyperemia. The occurrence of such hyperemia can be inhibited by pre-injection (3 hours) of antisera from rabbits immunized with gonadotropin extracts. It is demonstrated that the retained capacity of gonadotropin to induce hyperemia following antisera injections is greater when the...

Through the use of immunohistochemical techniques, human chorionic gonadotropin has been localized to syncytiotrophoblastic cells of immature placenta, hydatidiform mole, chorioadenoma destruens, and choriocarcinoma. No gonadotropin has been detected in cytotrophoblast. Evidence is discussed which suggests that syncytiotrophoblast is the cell of origin of human chorionic gonadotropin. The obser...

The role of RNA synthesis was investigated in the action of chorionic gonadotropin on ovaries of immature rats. Chorionic gonadotropin accelerates the ovarian incorporation of [3H]uridine in uivo into rapidly labeled nuclear RNA within 10 min after hormone injection. Analysis of the RNA base composition, expressed as base ratio (A + U):(G + C), shows that hormonal stimulation of the rate of [3H...

A new commercially available chemiluminescence immunoassay for the quantitative measurement of human chorionic gonadotropin and its beta-subunit in serum was compared with the enzyme immunoassay used in our routine laboratory. Human chorionic gonadotropin was determined in serum from pregnant women, as well as from women with abortus imminens, suspected ectopic pregnancies or with molar pregnan...

Citation: Younis JS (2017) Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis. Front. Endocrinol. 8:264. doi: 10.3389/fendo.2017.00264 Commentary: efficacy of FollicleStimulating Hormone (FS...

A crude hCG with an activity of about 3,000 IU per mg was purifed to 10,000--15,000 IU per mg of dry weight using Amberlite CG-50 chromatography combined with DEAE-Sephadex A-50 and Sephadex G-75. The alpha and beta subunits of hCG were prepared by urea-treatment of the hormone and isolated by DEAE-Sephadex A-50 chromatography. Further purification of the subunits was achieved by gel filtration...

With the increasing use of gonadotropin releasing hormone antagonist protocols, it has become an option to trigger ovulation with gonadotropin releasing hormone agonist which has several advantages over human chorionic gonadotropin triggering; among those an elimination or reduction in ovarian hyperstimulation syndrome, and a reduction in luteal phase discomfort. Thus, this paper questions the ...